BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

15 articles for M Jarman

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Analogues of aminoglutethimide based on 1-phenyl-3-azabicyclo[3.1.0]hexane-2,4-dione: selective inhibition of aromatase activity.EBI
Institute of Cancer Research
Analogues of aminoglutethimide: selective inhibition of aromatase.EBI
TBA
Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).EBI
The Institute of Cancer Research
The 16,17-double bond is needed for irreversible inhibition of human cytochrome p45017alpha by abiraterone (17-(3-pyridyl)androsta-5, 16-dien-3beta-ol) and related steroidal inhibitors.EBI
Institute of Cancer Research
Analogues of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage.EBI
TBA
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors.EBI
The Institute of Cancer Research
Solid-phase synthesis of novel inhibitors of farnesyl transferase.EBI
Institute of Cancer Research
3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancer.EBI
Cancer Research Campaign Centre For Cancer Therapeutics
Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer.EBI
Institute of Cancer Research
Esters of 3-pyridylacetic acid that combine potent inhibition of 17 alpha-hydroxylase/C17,20-lyase (cytochrome P45017 alpha) with resistance to esterase hydrolysis.EBI
Crc Laboratory
Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.EBI
Institute of Cancer Research
Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents.EBI
TBA
Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives.EBI
Institute of Cancer Research
Hydroxyperfluoroazobenzenes: novel inhibitors of enzymes of androgen biosynthesis.EBI
Institute of Cancer Research
Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes.BDB
TBA